The potential cost-effectiveness of infant pneumococcal vaccines in Australia.

@article{Newall2011ThePC,
  title={The potential cost-effectiveness of infant pneumococcal vaccines in Australia.},
  author={Anthony T. Newall and Prudence Creighton and David J. Philp and James G. Wood and C. Macintyre},
  journal={Vaccine},
  year={2011},
  volume={29 45},
  pages={8077-85}
}
Over the last decade infant pneumococcal vaccination has been adopted as part of routine immunisation schedules in many developed countries. Although highly successful in many settings such as Australia and the United States, rapid serotype replacement has occurred in some European countries. Recently two pneumococcal conjugate vaccines (PCVs) with extended serotype coverage have been licensed for use, a 10-valent (PHiD-CV) and a 13-valent (PCV-13) vaccine, and offer potential replacements for… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…